tirzepatide hydration effects weight loss 2025 Maximizing with Semaglutide/Tirzepatide: Managing Side Through Nutrition and Tirzepatide vs. Semaglutide: Which is

GLP-1 Receptor Agonist Market Report Snapshot Market Segmentation By Molecule (Liraglutide, Dulaglutide, Semaglutide, Tirzepatide, and Others): The tirzepatide segment earned USD 27.14 billion in 2025, primarily due to superior efficacy in both glycemic control and weight reduction, rapid uptake among healthcare providers, and expanded diabetes and obesity indications, positioning it as a preferred GLP-1 therapy option

Awareness of the needs of gastroparesis patients can lead to better management strategies and improved quality of life, Ceciel T

Exploring the GLP-1-GLP-1R axis in porcine pancreas and gastrointestinal tract in vivo by ex vivo autoradiography

Aging 22, 403406